Beyond the Chatbots: Alger's Dr. Crawford on AI, Robotics, and Healthcare Innovation
Concentration in benchmarks is a live question for advisors building client portfolios, and this offers one active manager's framing of it plus her thematic views on AI, robotics and healthcare. Useful as a short check on how a high-conviction manager describes positioning in a narrow market.
Summary
By the etfs deskRecorded at the ETF Oasis at Future Proof, the video features Alger's Dr. Ankur Crawford discussing whether concentration in the equity market is a risk or an opportunity. She explains the case for a high-conviction, 30-stock portfolio as a response to a concentrated market, and gives her views on AI being in its early innings, robotics as a possible spark for a US industrial renaissance, and where she sees innovation in healthcare.
- Frames market concentration as a question of risk versus opportunity
- Presents a high-conviction, 30-stock portfolio as a possible answer to a concentrated market
- Says she believes AI is only in its early innings
- Points to robotics as a potential spark for a US industrial renaissance, and to innovation in healthcare
Similar items
Same topic Half the S&P Is One AI Trade. This Isn’t 1999. What If the Bubble Is in the Safe Stocks? | TQTwo Quants and a Financial Planner (Excess Returns) |
 Behind the Ticker: Milliman's 2 ETFs Built to Keep Pace with Healthcare Inflation | ECETF.com |
 Half the S&P Is One AI Trade. This Isn’t 1999. What If the Bubble Is in the Safe Stocks? | ERExcess Returns |
 Are Energy Stocks Still Cheap? | CRThe Compound (Ritholtz Wealth) |
 5,500 ETFs and Counting: MSCI Asks Advisors Where the Market Goes Next | ECETF.com |
Get the weekly 3 to watch
Free, in the Morning BriefEvery week the Morning Brief picks three videos and podcasts worth your time, with why each one matters.
Free. Every morning. Unsubscribe from any edition in one click.
Videos and podcasts are embedded from their publishers. Selections and summaries are editorial and are not investment advice.